Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

ETF Prime: New Launches Surge Past 370 in 2026

BY | ETF Database
10:45 am ET 05/06/26 | 4 VIEWS
Kirsten Chang, senior industry analyst at VettaFi, joined Nate Geraci on this week’s ETF Prime to discuss the relentless pace of new ETF launches in 2026. The industry has launched nearly 370 new ETFs in just over four months. It is tracking toward 1,100 to 1,200 launches for the year, matching the record set in 2025, according to Chang.Key Takeaways: ETF industry launches 370 products in four months, tracking toward 1,200 for the year. Procure Space ETF grows from $50M to $700M as issuers position for SpaceX IPO. Milliman launches healthcare inflation ETFs targeting 7% and 9% returns respectively. Active managers dominate the new launches, with approximately 80% using active management. Chang described this shift as the democratization of the hedge fund. Meanwhile, the ProShares Genius Money Market ETF (IQMM) ranks as the top launch of 2026, exceeding $22 billion in assets. However, much of that growth comes from internal cash management, she said. Space ETFs have attracted significant attention as issuers position ahead of a potential SpaceX IPO valued near $1.5 trillion, Chang noted. The Procure Space ETF (UFO ) has grown from $50 million to $750 million in assets over the past year. Recent entrants include the Roundhill Space & Technology ETF (MARS), the Tema Space Innovators ETF (NASA), and the Global X Space Tech ETF (ORBX), all competing with targeted tickers.Thematic Innovation AcceleratesWithin artificial intelligence infrastructure, Chang highlighted granular plays such as the Roundhill Memory ETF (DRAM). The fund hit $1 billion in 10 days and now holds $3 billion in assets. Similarly, the Sprott Rare Earths ex-China ETF (REXC) targets supply chain diversification for materials critical to the green energy economy and electric vehicles. The strategy specifically aims to reduce dependence on Chinese monopolies, according to Chang. On the active management front, Fidelity expanded its systematic active lineup with four new ETFs: the Fidelity Enhanced Small Cap Growth ETF (FSEG), the Fidelity Enhanced Mid Cap Growth ETF (FEMG), the Fidelity Enhanced Small Cap Value ETF (FSEV), and the Fidelity Enhanced Mid Cap Value ETF (FEMV). Priced at 23 to 28 basis points, the funds represent aggressive competition for traditional active managers, Chang said. See more: Fidelity Expands Enhanced Suite With Mid- & Small-Cap ETFs Adam Schenck, principal and managing director at Milliman Financial Risk Management, discussed the firm’s entry into the ETF space. The firm launched two healthcare inflation-focused funds. The Milliman Healthcare Inflation Guard ETF (MHIG) targets returns commensurate with healthcare inflation at approximately 7%. In contrast, the Milliman Healthcare Inflation Plus ETF (MHIP) aims to overshoot healthcare inflation by 200 basis points, Schenck said. Milliman advises on $242 billion in assets and uses proprietary Health Trend Guidelines based on claims data. For more ETF Prime podcast episodes, visit our ETF Prime Content Hub. VettaFi LLC (“VettaFi”) is the index provider for UFO, for which it receives an index licensing fee. However, UFO is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of UFO.

More Commentary

GAMR Soars as AMD & AI Chips Power Gaming Rally
BY | ETF Database
7:35 am ET 05/06/26 | 30 VIEWS
American Centurys Greenblath on Bond Outlook
BY | ETF Database
8:20 am ET 05/06/26 | 14 VIEWS
Nvidias New Corning Deal: A Boost for Momentum ETFs
BY | ETF Database
11:30 am ET 05/06/26 | 5 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.